|
Volumn 20, Issue 7, 2010, Pages 1021-1027
|
CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
BONE DENSITY CONSERVATION AGENT;
CALCITRIOL;
CALCINOSIS;
CHRONIC DISEASE;
DIALYSIS;
EVIDENCE BASED MEDICINE;
HUMAN;
INTERNATIONAL COOPERATION;
KIDNEY DISEASE;
KIDNEY TRANSPLANTATION;
METABOLIC BONE DISEASE;
PRACTICE GUIDELINE;
REVIEW;
SECONDARY HYPERPARATHYROIDISM;
TREATMENT OUTCOME;
VASCULAR DISEASE;
BONE DENSITY CONSERVATION AGENTS;
BONE DISEASES, METABOLIC;
CALCINOSIS;
CALCITRIOL;
CHRONIC DISEASE;
DIALYSIS;
DIPHOSPHONATES;
EVIDENCE-BASED MEDICINE;
HUMANS;
HYPERPARATHYROIDISM, SECONDARY;
INTERNATIONAL COOPERATION;
KIDNEY DISEASES;
KIDNEY TRANSPLANTATION;
PRACTICE GUIDELINES AS TOPIC;
TREATMENT OUTCOME;
VASCULAR DISEASES;
|
EID: 77957683350
PISSN: 09175857
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (4)
|
References (0)
|